|Bid||1.4000 x 2200|
|Ask||1.4300 x 1300|
|Day's Range||1.4100 - 1.4300|
|52 Week Range||1.1000 - 2.1800|
|Beta (3Y Monthly)||-0.54|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 7, 2017 - Aug 11, 2017|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.21|
Marrone Bio Innovations Inc. (MBII) (MBI), a leading developer of biological crop protection and plant health solutions, has received a notice of allowance from the U.S. Patent and Trademark Office for key claims covering the composition and method of manufacturing for Grandevo WDG, an MBI developed microbial-based bioinsecticide. A Notice of Allowance is a document sent to a patent applicant from the United States Patent and Trademark Office after a patent examiner has decided to issue the requested patent.
The cannabis industry has grown in recent months and years, and many companies in the cannabis and health-related industries have been uplisted to reputable U.S. exchanges. Learn about the marijuana stocks on the Nasdaq.
Marrone Bio Innovations has released the results of a 2018 study on the impact of Venerate® XC and Grandevo® WDG on almond pests. The addition of Venerate® XC reduced the total nut damage due to navel orangeworm, Amyelois transitella, by an additional two percent. This pest has developed a resistance to a number of conventional chemical pesticides.
Crop protection data for 2018 are now available. The overall market increased from $54.3 billion in 2017 to $57.6, fungicides and insecticides comprised a $ billion in 2018. Marrone (MBII) has interests in Mexico and is working to further relationships in Latin America.
DAVIS, Calif., May 21, 2019 -- Marrone Bio Innovations, Inc. (the “Company” or “MBI”) (NASDAQ: MBII), a leading developer of bio-based products for pest management and plant.
Marrone Bio (MBII) has formed a collaboration with Compass Minerals Plant Nutrition (CMP) to develop new plant nutrition products (enhanced fertilizers) that are combined with microorganism that promote the absorption of nutrients in a more efficient manner. Marrone Bio will provide access to its comprehensive library of 18,000 microorganisms and CMPN will apply its knowledge of plant nutrition to develop novel systems that promote plant development and increased crop yields. There are many bacteria and fungi in soil that are known to improve the take-up of plant nutrients and increase root health.
Davis-based Marrone Bio Innovations Inc. said it will collaborate with Compass Minerals to develop new sustainable fertilizer products.
Compass Minerals Plant Nutrition, a division of Compass Minerals (CMP), a leading developer and manufacturer of specialty plant nutrition solutions, and Marrone Bio Innovations Inc. (MBII), a leading developer of bio-based products for pest management and plant health, today announced that the two companies have formed a collaboration to develop new specialty plant nutrient products enhanced with microorganisms. The new products will be developed with patented technologies aimed at helping crops take up nutrients more efficiently, to increase crop health and reduce crop stress.
Shares of the publicly traded company rose to their highest level in almost seven months, after the first-quarter earnings release.
DAVIS, Calif., May 09, 2019 -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable biopesticide and plant health solutions, has provided its.
DAVIS, Calif., May 01, 2019 -- Marrone Bio Innovations Inc. (NASDAQ:MBII) (MBI), a leading developer of biological crop protection and plant health solutions, today announced.
DAVIS, Calif., April 25, 2019 -- Marrone Bio Innovations Inc. (NASDAQ: MBII) (MBI), an international leader in smart biopesticide and plant health solutions, will release.
The Digital Issue of the Spring 2019 MicroCap Review Magazine,The Official Magazine for the MicroCap Stock Market, can be read on www.StockNewsNow.com LOS ANGELES, CA / ACCESSWIRE / April 23, 2019 / SNN ...
As the global market demand for almonds continues to increase exponentially, one of the greatest threats to crops is navel orangeworm, Amyelois transitella. According to a 2018 study by Sacramento-based Blue Diamond Growers, Almond growers are at risk of losing 20 percent of their crop due to this increasingly common pest, which causes an estimated revenue loss to the farmer of $1,700 per acre. The addition of a bioinsecticide from Marrone Bio Innovations Inc. (MBII) (MBI), a leading developer of biological crop protection and plant health solutions – to the May and hull split conventional spray programs decreased total nut damage by an additional two percent in extensive 2018 field trials.
By Ian Gilson, PhD, CFA NASDAQ:MBII READ THE FULL MBII RESEARCH REPORT Marrone Bio Innovations' (NASDAQ:MBII) Regalia Maxx is now on sale in Western Canada through TerraLink Horticulture, Inc. TerraLink, ...
DAVIS, Calif., April 16, 2019 -- Marrone Bio Innovations Inc. (NASDAQ:MBII) (MBI), a leading developer of biological crop protection and plant health solutions, today announced.
Marrone Bio Innovations (MBII) has announced that Regalia Maxx has received label approval from Canada's Pest Management Regulatory Agency for use on marijuana (Canadian:marihuana) crops in Canada. A new distributor, Plant Products Inc., has Regalia Maxx listed on its web site as Item # 21137 available in 5L containers.
DAVIS, Calif., April 10, 2019 -- Marrone Bio Innovations Inc. (NASDAQ:MBII) (MBI), a leading developer of biological crop protection and plant health solutions, today announced.
Research has initiated coverage on Marrone Bio Innovations (MBII) with a $2.00 price target. Fourth quarter revenue was ahead of projections due to better than expected sales of Venerate. In Dec. 2018 Marrone launched TerraConnect, a new biological soil applied and seed treatment platform delivering high performance products with a broad range of tools to improve and protect crops.
DAVIS, Calif., March 25, 2019 -- Marrone Bio Innovations, Inc. (MBI) (NASDAQ: MBII), a leading global provider of bio-based pest management and plant health products, today.
Crop protection and plant health solutions company Marrone Bio Innovations Inc (NASDAQ: MBII ) reported financial results for the fourth quarter and full year Thursday. The Davis, California-based company ...
Fourth Quarter 2018 Revenues Grew 72% to $5.7 Million; Fiscal Year 2018 Revenues Increased 17% to $21.2 Million Fourth Quarter 2018 Gross Margins Expanded to 50.5%; Annual Gross Margins Expanded to 48.6% ...
If you want to know who really controls Marrone Bio Innovations, Inc. (NASDAQ:MBII), then you'll have to look at the makeup of its share registry. Large companies usually have institutionsRead More...